about
A tale of three fingers: the family of mammalian Sp/XKLF transcription factorsThe European dimension for the mouse genome mutagenesis programInducible model for beta-six-mediated site-specific recombination in mammalian cells.Expanding the scope of site-specific recombinases for genetic and metabolic engineeringToxin-based therapeutic approachesStrategies to achieve conditional gene mutation in miceCodon-improved Cre recombinase (iCre) expression in the mouseConditional gene manipulation: Cre-ating a new biological eraMolecular neuroanatomy's "Three Gs": a primerProtamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cellsThe transmission of nuclear pore complexes to daughter cells requires a cytoplasmic pool of Nsp1Recombination-induced tag exchange to track old and new proteins.Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists.FLP and Cre recombinase function in Xenopus embryosCREB required for the stability of new and reactivated fear memories.Temporally and spatially regulated somatic mutagenesis in mice.A chimeric Cre recombinase inducible by synthetic,but not by natural ligands of the glucocorticoid receptorModeling cancer in mice.Pharmacologically regulated induction of silent mutations (PRISM): combined pharmacological and genetic approaches for learning and memory.Targeted plasmid integration into the human genome by an engineered zinc-finger recombinaseDeciphering the renal code: advances in conditional gene targeting.Current issues in mouse genome engineering.Regulated gene insertion by steroid-induced PhiC31 integrase.The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis.Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice.Recombinase technology: applications and possibilitiesGenetic approaches to study glial cells in the rodent brain.Unparalleled control of neural activity using orthogonal pharmacogenetics.Targeted mutagenesis tools for modelling psychiatric disorders.Essentials of recombinase-based genetic fate mapping in mice.Regulation of Cre recombinase activity by the synthetic steroid RU 486.New variants of inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility.The histone methyltransferase KMT2B is required for RNA polymerase II association and protection from DNA methylation at the MagohB CpG island promoterControlling gene expression in yeast by inducible site-specific recombination.Inducible site-directed recombination in mouse embryonic stem cellsA simple assay to determine the functionality of Cre or FLP recombination targets in genomic manipulation constructs.FLP-mediated recombination of FRT sites in the maize genome.Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination.Inducible expression based on regulated recombination: a single vector strategy for stable expression in cultured cells.Recent advances in gene mutagenesis by site-directed recombination.
P2860
Q24548846-02965E65-1E02-48A7-B4FB-A7BA84653D97Q24644441-26D21EDE-1D42-47E9-A95C-28C4F1D05701Q25256760-26E393F2-D863-43F5-A91A-47C287903011Q26995224-6C00014A-27F4-4CA1-AB4A-3DF873BCD8D4Q27013664-9C6F7CCD-E1CF-4FE4-8C89-EC6E020EF61FQ27023444-903A1CF5-4090-4BDC-9A31-D1EB56544452Q28218096-C7C98E75-275F-4505-91BD-DC9818919483Q28270282-F4ADADA8-7526-4D95-992E-3B7EC536E4B6Q28296492-CC54B68A-675D-419F-8133-CA20283F29FCQ29618298-45A5335F-473C-43DC-A704-2B566AA59B1DQ30555736-9468FF21-F227-44DD-AD0E-0D30E2EF7DE2Q33591551-D802B47D-726D-4625-BAA1-E34D47741C15Q33888199-DA3D40D2-1F31-4835-978D-62AA7AA626A9Q33939154-061A9FC3-56E0-43B9-AE3F-4C82780336F0Q34117934-FDF630A3-3D44-4173-9B16-DE1862EE0A60Q34659147-76300F61-4439-4987-A46B-C1733B83CD36Q34675174-E7E930C5-F164-40E7-9534-0E5F00834F3DQ34770630-E6C7E537-97B1-4DD2-AD61-1E69B96C11E7Q35112188-C49E3558-6029-4561-8EC9-4494BA607455Q35224339-08EA672F-DC62-4612-952A-532C5E22F1B2Q35894395-374B4FC0-CA9B-4F11-B967-708BE6E31BEBQ36299352-B74F3F2F-C380-471D-BB7B-804923E02943Q36740084-2DD7AF4F-BA74-4689-B295-FE4C265ADDD1Q37172487-97C51292-25C3-4D5F-BEA7-9588412937CCQ37577945-55B1E486-04E8-433A-AE66-B711F8E043CDQ37802791-0D8D750B-E79B-4BD3-993C-7B01E47DA2ADQ37967602-AF13EC42-70A0-40F7-96C7-027A471EFF4DQ38034970-F8769EE9-1E62-476A-94C2-C102E3E328CFQ38146885-2389FDF0-91BE-406D-B791-B5D785BE985FQ38169600-1A58830F-35D3-4727-806B-65751039F27EQ38359006-633A701B-076C-4F82-A983-5CE4FAFEF1D3Q39086370-5F005A1D-5F0C-4557-AE99-BB7F61408606Q39203046-6DE16D89-192C-4999-B575-3C5B817EBB65Q39607714-03CC4DDF-7A9E-425A-AC4A-E4E048613B58Q39715564-157762E1-D067-428C-85E0-F5571116F27FQ39717021-D009B142-9463-457F-B11A-0CA5FF41F803Q39717515-9C20D727-D999-4F73-AD45-8CB5B1D63818Q39717984-582DB873-1798-40D5-B5B5-2FF780006FB4Q39724352-08ADE8E6-C8C9-4300-B426-CC5CCC3EF310Q39763898-CA9F51E0-4A07-4EF5-B8AA-2558880657EC
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Ligand-regulated site-specific recombination
@ast
Ligand-regulated site-specific recombination
@en
Ligand-regulated site-specific recombination
@nl
type
label
Ligand-regulated site-specific recombination
@ast
Ligand-regulated site-specific recombination
@en
Ligand-regulated site-specific recombination
@nl
prefLabel
Ligand-regulated site-specific recombination
@ast
Ligand-regulated site-specific recombination
@en
Ligand-regulated site-specific recombination
@nl
P2860
P356
P1476
Ligand-regulated site-specific recombination
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.13.5940
P407
P577
1995-06-01T00:00:00Z